Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Multiple Myeloma 277Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Recurrence 43Neoplasms, Plasma Cell 32Leukemia 29Lymphoma 25Neoplasms 23Vomiting 21Burkitt Lymphoma 20Lymphoma, Non-Hodgkin 19Nausea 17Immunoglobulin Light-chain Amyloidosis 17Lymphoma, Mantle-Cell 16Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 14Waldenstrom Macroglobulinemia 13Lymphoma, Follicular 13Breast Neoplasms 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myeloid, Acute 10Lymphoma, B-Cell, Marginal Zone 9Amyloidosis 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Neoplasm Metastasis 7Hematologic Neoplasms 7Smoldering Multiple Myeloma 6Ovarian Neoplasms 6Lung Neoplasms 6

Interventions

Mifepristone 3Corlux 3Thyrotropin-Releasing Hormone 1Hydrocortisone 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pituitary Diseases × Dexamethasone × Clear all
NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed
43 enrolled 8 charts
Endocrine

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡